Strength Seen in Henry Schein (HSIC): Can Its 5.4% Jump Turn Into More Strength?
Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching
Henry Schein, Inc. (NASDAQ:HSIC), is not the largest company out there, but it saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$74.74 and falling
Does Henry Schein (HSIC) Have Compelling Growth Prospects?
Morgan Stanley Adjusts Henry Schein's Price Target to $60 From $65
Henry Schein (HSIC) has an average rating of hold and price targets ranging from $60 to $92, according to analysts polled by Capital IQ.
Is It Wise to Retain Henry Schein (HSIC) in Your Portfolio Now?
Morgan Stanley Maintains Henry Schein(HSIC.US) With Sell Rating, Cuts Target Price to $60
Morgan Stanley analyst Erin Wright maintains $Henry Schein(HSIC.US)$ with a sell rating, and adjusts the target price from $65 to $60.According to TipRanks data, the analyst has a success rate of 64.7
Henry Schein (HSIC) Gets a Sell From Morgan Stanley
Express News | Henry Schein, Inc. : Morgan Stanley Cuts Target Price to $60.00 From $65.00
Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
Henry Schein Hosts Ribbon Cutting Ceremony to Celebrate New Southwestern Distribution Center
Facility Designed To Improve Efficiency, Enable Innovation, and Better Serve Customers; Modernized, 811K Square Foot Facility in Fort Worth Largest in the Company's Network Henry Schein, Inc. (NASDAQ:HSIC), the
Express News | Evercore ISI Group Maintains In-Line on Henry Schein, Lowers Price Target to $72
Express News | Henry Schein Inc : Leerink Partners Cuts Target Price to $72 From $77
Lumos Diagnostics Expands Distribution Deal With Henry Schein for Respiratory Infection Test
Lumos Diagnostics (ASX:LDX) extended its agreement with Henry Schein Medical's European business for the FebriDx acute respiratory infection test, expanding its distribution to include Belgium, accord
Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Breaking Down Henry Schein: 4 Analysts Share Their Views
Ratings for Henry Schein (NASDAQ:HSIC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings, showc
Barrington Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $92
Barrington analyst Michael Petusky maintains $Henry Schein(HSIC.US)$ with a buy rating, and maintains the target price at $92.According to TipRanks data, the analyst has a success rate of 49.0% and a
Maintained OUTPERFORM Rating for Henry Schein Amidst Recovery and Growth Prospects
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials?
With its stock down 15% over the past three months, it is easy to disregard Henry Schein (NASDAQ:HSIC). We, however decided to study the company's financials to determine if they have got anything t
ZimVie May Be Worth $25-$29 a Share in Takeover -analyst